These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 34930226)

  • 21. Menstrual and Reproductive Factors in Association With Breast Cancer Risk in Vietnamese Women: A Case-Control Study.
    Bui OT; Tran HT; Nguyen SM; Dao TV; Bui QV; Pham AT; Shrubsole MJ; Cai Q; Ye F; Zheng W; Luu HN; Tran TV; Shu XO
    Cancer Control; 2022; 29():10732748221140206. PubMed ID: 36373740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reproductive behaviors and risk of developing breast cancer according to tumor subtype: A systematic review and meta-analysis of epidemiological studies.
    Lambertini M; Santoro L; Del Mastro L; Nguyen B; Livraghi L; Ugolini D; Peccatori FA; Azim HA
    Cancer Treat Rev; 2016 Sep; 49():65-76. PubMed ID: 27529149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of breast cancer risk factors among molecular subtypes: A case-only study.
    Zhang L; Huang Y; Feng Z; Wang X; Li H; Song F; Liu L; Li J; Zheng H; Wang P; Song F; Chen K
    Cancer Med; 2019 Apr; 8(4):1882-1892. PubMed ID: 30761775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiological risk factors associated with inflammatory breast cancer subtypes.
    Atkinson RL; El-Zein R; Valero V; Lucci A; Bevers TB; Fouad T; Liao W; Ueno NT; Woodward WA; Brewster AM
    Cancer Causes Control; 2016 Mar; 27(3):359-66. PubMed ID: 26797453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reproductive risk factors in relation to molecular subtypes of breast cancer: Results from the nurses' health studies.
    Sisti JS; Collins LC; Beck AH; Tamimi RM; Rosner BA; Eliassen AH
    Int J Cancer; 2016 May; 138(10):2346-56. PubMed ID: 26684063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association between body mass index and immunohistochemical subtypes in breast cancer.
    Sahin S; Erdem GU; Karatas F; Aytekin A; Sever AR; Ozisik Y; Altundag K
    Breast; 2017 Apr; 32():227-236. PubMed ID: 27756509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of adiposity, dysmetabolisms, and inflammation with aggressive breast cancer subtypes: a cross-sectional study.
    Agresti R; Meneghini E; Baili P; Minicozzi P; Turco A; Cavallo I; Funaro F; Amash H; Berrino F; Tagliabue E; Sant M
    Breast Cancer Res Treat; 2016 May; 157(1):179-89. PubMed ID: 27117160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lifetime personal cigarette smoking and risk of young-onset breast cancer by subtype among non-Hispanic Black and White women in the Young Women's Health History Study.
    Ihenacho U; Hamilton AS; Mack WJ; Wu AH; Unger JB; Pathak DR; Hirko KA; Houang RT; Press MF; Schwartz KL; Marcus LR; Velie EM
    Breast Cancer Res Treat; 2022 Oct; 195(3):353-366. PubMed ID: 35925453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Analysis of prolactin receptor expression in breast cancer subtypes].
    Kalinina TS; Kononchuk VV; Sidorov SV; Gulyaeva LF
    Biomed Khim; 2020 Jan; 66(1):89-94. PubMed ID: 32116231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer.
    Wunderle M; Pretscher J; Brucker SY; Volz B; Hartmann A; Fiessler C; Hein A; Häberle L; Jud SM; Lux MP; Janni W; Loehberg CR; Hartkopf AD; Walter CB; Baake G; Fridman A; Malter W; Wuerstlein R; Harbeck N; Hoffmann O; Kümmel S; Martin B; Thomssen C; Graf H; Wolf C; Bayer CM; Hack CC; Almstedt K; Gass P; Heindl F; Brodkorb TF; Nabieva N; Lindner C; Kolberg HC; Krabisch P; Weigel M; Steinfeld-Birg D; Kohls A; Brucker C; Schulz V; Fischer G; Pelzer V; Wallwiener D; Rack B; Fehm T; Rody A; Maass N; Beckmann MW; Fasching PA; Rauh C
    Breast Cancer Res Treat; 2019 Apr; 174(2):453-461. PubMed ID: 30603996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent Use of Oral Contraceptives and Risk of Luminal B, Triple-Negative, and HER2-Overexpressing Breast Cancer.
    Lorona NC; Cook LS; Tang MC; Hill DA; Wiggins CL; Li CI
    Horm Cancer; 2019 Jun; 10(2-3):71-76. PubMed ID: 30989580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast cancer molecular subtypes and survival in a hospital-based sample in Puerto Rico.
    Ortiz AP; Frías O; Pérez J; Cabanillas F; Martínez L; Sánchez C; Capó-Ramos DE; González-Keelan C; Mora E; Suárez E
    Cancer Med; 2013 Jun; 2(3):343-50. PubMed ID: 23930211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association Between Metabolic Syndrome and Immunohistochemical Profile at Breast Cancer Diagnosis in Postmenopausal Women.
    Motoki AH; Buttros DAB; Gaspar AL; Almeida-Filho BS; Carvalho-Pessoa E; Vespoli HDL; Nahas-Neto J; Nahas EAP
    Clin Breast Cancer; 2022 Feb; 22(2):e253-e261. PubMed ID: 34465534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reproductive factors, heterogeneity, and breast tumor subtypes in women of mexican descent.
    Martinez ME; Wertheim BC; Natarajan L; Schwab R; Bondy M; Daneri-Navarro A; Meza-Montenegro MM; Gutierrez-Millan LE; Brewster A; Komenaka IK; Thompson PA
    Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1853-61. PubMed ID: 23950213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The diverse distribution of risk factors between breast cancer subtypes of ER, PR and HER2: a 10-year retrospective multi-center study in China.
    Song Q; Huang R; Li J; Fan J; Zheng S; Zhang B; Yang H; Tang Z; He J; Xie X; Li H; Li J; Qiao Y
    PLoS One; 2013; 8(8):e72175. PubMed ID: 23977244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes].
    Zhang HM; Zhang BN; Xuan LX; Zhao P
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):447-51. PubMed ID: 19950556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger.
    Gaudet MM; Press MF; Haile RW; Lynch CF; Glaser SL; Schildkraut J; Gammon MD; Douglas Thompson W; Bernstein JL
    Breast Cancer Res Treat; 2011 Nov; 130(2):587-97. PubMed ID: 21667121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical features and prognosis of patients with first-episode liver metastasis of different molecular subtypes of breast cancer].
    Wu SY; Tan Y; Guan YS
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):422-8. PubMed ID: 27465945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reproductive risk factors associated with breast cancer in young women by molecular subtype.
    Ruddy KJ; Vierkant RA; Jahan N; Higgins A; Partridge A; Larson N; Radisky DC; Couch F; Olson J; Sherman ME
    Breast; 2022 Dec; 66():272-277. PubMed ID: 36375388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insights from a Long-Term Follow-Up Evaluation of Early Breast Cancer Outcomes by Tumor Subtype.
    Zanardi E; Di Meglio A; Boccardo C; Zinoli L; Salvi S; Rubagotti A
    Oncol Res Treat; 2020; 43(7-8):362-371. PubMed ID: 32512573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.